SOLV · Company research
Solventum Corporation (SOLV): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
34records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance UK | Solventum Corporation (SOLV) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 19, 2026 | neutral | 0 | 0.6 |
| Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Singapore | Solventum Corporation (SOLV) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 19, 2026 | neutral | 0 | 0.6 |
| FDA clears two wound treatments for combined use, which may allow fewer dressing changes. - Stock Titan | FDA clears two wound treatments for combined use, which may allow fewer dressing changes. Stock Titan | View source ↗ | Stock Titan | Oct 19, 2026 | neutral | 0 | 0.6 |
| SOLV Oct 2026 100.000 put (SOLV261016P00100000) stock price, news, quote and history - Yahoo Finance UK | SOLV Oct 2026 100.000 put (SOLV261016P00100000) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 17, 2026 | neutral | 0 | 0.6 |
| SOLV Nov 2026 110.000 call (SOLV261120C00110000) Stock Price, News, Quote & History - Yahoo! Finance Canada | SOLV Nov 2026 110.000 call (SOLV261120C00110000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| Precision Trading with Solventum Corporation When-issued (SOLV) Risk Zones - Stock Traders Daily | Precision Trading with Solventum Corporation When-issued (SOLV) Risk Zones Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| SOLV Apr 2027 85.000 put (SOLV270416P00085000) Interactive Stock Chart - Yahoo! Finance Canada | SOLV Apr 2027 85.000 put (SOLV270416P00085000) Interactive Stock Chart Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Solventum Corporation (SOLV) Stock Price, News, Quote & History - Yahoo! Finance Canada | Solventum Corporation (SOLV) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results. - Stock Titan | At 4:30 p.m. Eastern on Nov. 5, Solventum will discuss its quarterly results. Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| Top SOLV Energy (MWH) Competitors 2026 - MarketBeat | Top SOLV Energy (MWH) Competitors 2026 MarketBeat | View source ↗ | MarketBeat | Oct 13, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 12, 2026 | neutral | 0 | 0.6 |
| Solventum (SOLV) Could Be 6% Undervalued On Rising Earnings Optimism - Simply Wall Street | Solventum (SOLV) Could Be 6% Undervalued On Rising Earnings Optimism Simply Wall Street | View source ↗ | Simply Wall Street | Oct 10, 2026 | neutral | 0 | 0.6 |
| SOLV Apr 2027 100.000 call (SOLV270416C00100000) stock price, news, quote and history - Yahoo Finance UK | SOLV Apr 2027 100.000 call (SOLV270416C00100000) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| SOLV: Solventum Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | SOLV: Solventum Corp Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| China Sterilization Equipment Market Outlook to 2033 - Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities | ResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector. | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | neutral | 0 | 1 |
| China Sterilization Equipment Market Outlook to 2033 - Chemical, Physical and Ultraviolet Sterilizers | Revenue, Volume and Pricing Trends Reveal Growth Opportunities | ResearchAndMarkets.com released a comprehensive market report on China's sterilization equipment industry covering chemical, physical, and ultraviolet sterilizers. The report provides revenue, volume, and pricing data from 2018-2033, competitive analysis of major players, and strategic insights for market entry and expansion in this growing sector. | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | neutral | 0 | 1 |
| China Patient Examination Devices Market Size, Share, and Forecast to 2033 - Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion | A comprehensive market report on China's patient examination devices market covering thermometers and stethoscopes through 2033. The report provides revenue, volume, and pricing data for medical device manufacturers, investors, and healthcare stakeholders, with 2025 company share analysis and competitive intelligence on key market players. | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | neutral | 0 | 1 |
| China Patient Examination Devices Market Size, Share, and Forecast to 2033 - Thermometers and Stethoscopes | Pricing Trends and Growth Opportunities Guide Expansion | A comprehensive market report on China's patient examination devices market covering thermometers and stethoscopes through 2033. The report provides revenue, volume, and pricing data for medical device manufacturers, investors, and healthcare stakeholders, with 2025 company share analysis and competitive intelligence on key market players. | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | neutral | 0 | 1 |
| Solventum Corporation (SOLV) stock price, news, quote and history - Yahoo Finance Australia | Solventum Corporation (SOLV) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 9, 2026 | neutral | 0 | 0.6 |
| Is SOLV Energy (MWH) A Bargain On Growth Despite Its Share Price Slide? - Yahoo Finance | Is SOLV Energy (MWH) A Bargain On Growth Despite Its Share Price Slide? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? | Solventum (SOLV), a medical services company, demonstrates a strong track record of beating earnings estimates, with an average surprise of 21.57% over the last two quarters. The company's positive Earnings ESP of +2.81% combined with its Zacks Rank #3 suggests another earnings beat is likely in the near term. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? | Solventum (SOLV), a medical services company, demonstrates a strong track record of beating earnings estimates, with an average surprise of 21.57% over the last two quarters. The company's positive Earnings ESP of +2.81% combined with its Zacks Rank #3 suggests another earnings beat is likely in the near term. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? | Solventum (SOLV), a medical services company, demonstrates a strong track record of beating earnings estimates, with an average surprise of 21.57% over the last two quarters. The company's positive Earnings ESP of +2.81% combined with its Zacks Rank #3 suggests another earnings beat is likely in the near term. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? - Yahoo Finance | Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Why Solventum (SOLV) is a Top Value Stock for the Long-Term | Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 11.9 and has seen upward earnings estimate revisions, with an average earnings surprise of +13.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Why Solventum (SOLV) is a Top Value Stock for the Long-Term | Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 11.9 and has seen upward earnings estimate revisions, with an average earnings surprise of +13.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Why Solventum (SOLV) is a Top Value Stock for the Long-Term | Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a stock to watch with a #3 (Hold) Zacks Rank and a VGM Score of B. The company features attractive valuation metrics with a forward P/E ratio of 11.9 and has seen upward earnings estimate revisions, with an average earnings surprise of +13.2%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Why Did SOLV Energy (MWH) Move And Draw Fresh Attention? - Simply Wall Street | Why Did SOLV Energy (MWH) Move And Draw Fresh Attention? Simply Wall Street | View source ↗ | Simply Wall Street | Oct 8, 2026 | neutral | 0 | 0.6 |
| How to Find Strong Medical Stocks Slated for Positive Earnings Surprises | The article explains how to identify medical stocks poised for earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool. It highlights that combining a positive ESP with a Zacks Rank #3 or better has historically produced 70% positive surprises and 28.3% average annual returns. Two medical stocks are featured as examples: Solventum (SOLV) with a +2.81% ESP and ANI Pharmaceuticals (ANIP) with a +6.45% ESP, both expected to report earnings in early November 2026. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | bullish | 1 | 1 |
| How to Find Strong Medical Stocks Slated for Positive Earnings Surprises | The article explains how to identify medical stocks poised for earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool. It highlights that combining a positive ESP with a Zacks Rank #3 or better has historically produced 70% positive surprises and 28.3% average annual returns. Two medical stocks are featured as examples: Solventum (SOLV) with a +2.81% ESP and ANI Pharmaceuticals (ANIP) with a +6.45% ESP, both expected to report earnings in early November 2026. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | bullish | 1 | 1 |
| Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names | Zacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP): CVS Health and Solventum. Both stocks have positive ESP figures and are expected to report earnings in early November 2026, suggesting potential for earnings beats based on recent analyst revisions. | View source ↗ | Zacks Investment Research | Oct 5, 2026 | bullish | 1 | 1 |
| Did Earnings Beat Just Shift Solventum (SOLV) Stock Investment Narrative? - Simply Wall Street | Did Earnings Beat Just Shift Solventum (SOLV) Stock Investment Narrative? Simply Wall Street | View source ↗ | Simply Wall Street | Sep 26, 2026 | neutral | 0 | 0.6 |
| 3 Reasons to Avoid SOLV and 1 Stock to Buy Instead - Yahoo Finance | 3 Reasons to Avoid SOLV and 1 Stock to Buy Instead Yahoo Finance | View source ↗ | Yahoo Finance | Aug 28, 2026 | neutral | 0 | 0.6 |
| Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans - Yahoo Finance | Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans Yahoo Finance | View source ↗ | Yahoo Finance | Aug 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.